BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 17363605)

  • 41. Inhibition of laryngeal cancer cell invasion and growth with lentiviral-vector delivered short hairpin RNA targeting human MMP-9 gene.
    Sun Y; Liu M; Yang B; Lu J; Li B
    Cancer Invest; 2008 Dec; 26(10):984-9. PubMed ID: 19093256
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural analysis of the human galectin-9 N-terminal carbohydrate recognition domain reveals unexpected properties that differ from the mouse orthologue.
    Nagae M; Nishi N; Nakamura-Tsuruta S; Hirabayashi J; Wakatsuki S; Kato R
    J Mol Biol; 2008 Jan; 375(1):119-35. PubMed ID: 18005988
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification and transcript analysis of a novel wallaby (Macropus eugenii) basal-like breast cancer cell line.
    Sharp JA; Mailer SL; Thomson PC; Lefèvre C; Nicholas KR
    Mol Cancer; 2008 Jan; 7():1. PubMed ID: 18179684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Effects of antisense 6 gene on colon cancer cells].
    Zhang ZY; Xu KS; Yang GY; Wang JS; Gao Y; Liu YF; Shuai J; Wang JY; Li SY; Shou NH; Niu J
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(37):2645-8. PubMed ID: 18162155
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Increased expression and altered intracellular distribution of adhesion/growth-regulatory lectins galectins-1 and -7 during tumour progression in hypopharyngeal and laryngeal squamous cell carcinomas.
    Saussez S; Decaestecker C; Lorfevre F; Chevalier D; Mortuaire G; Kaltner H; André S; Toubeau G; Gabius HJ; Leroy X
    Histopathology; 2008 Mar; 52(4):483-93. PubMed ID: 18315601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Galectins in hematological malignancies.
    Giordano M; Croci DO; Rabinovich GA
    Curr Opin Hematol; 2013 Jul; 20(4):327-35. PubMed ID: 23695449
    [TBL] [Abstract][Full Text] [Related]  

  • 47. TIMP-1 overexpression promotes tumorigenesis of MDA-MB-231 breast cancer cells and alters expression of a subset of cancer promoting genes in vivo distinct from those observed in vitro.
    Bigelow RL; Williams BJ; Carroll JL; Daves LK; Cardelli JA
    Breast Cancer Res Treat; 2009 Sep; 117(1):31-44. PubMed ID: 18787947
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
    Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
    Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A tumor-protective role for human kallikrein-related peptidase 6 in breast cancer mediated by inhibition of epithelial-to-mesenchymal transition.
    Pampalakis G; Prosnikli E; Agalioti T; Vlahou A; Zoumpourlis V; Sotiropoulou G
    Cancer Res; 2009 May; 69(9):3779-87. PubMed ID: 19383923
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Expression of galectin-1 in malignant tumors.
    Demydenko D; Berest I
    Exp Oncol; 2009 Jun; 31(2):74-9. PubMed ID: 19550395
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Galectin-1: a small protein with major functions.
    Camby I; Le Mercier M; Lefranc F; Kiss R
    Glycobiology; 2006 Nov; 16(11):137R-157R. PubMed ID: 16840800
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Galectins and urological cancer.
    Oka N; Takenaka Y; Raz A
    J Cell Biochem; 2004 Jan; 91(1):118-24. PubMed ID: 14689585
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of new diagnostic markers in pathology by focus on growth-regulatory endogenous lectins. The case study of galectin-7 in squamous epithelia.
    Chovanec M; Smetana K; Plzák J; Betka J; Plzáková Z; Stork J; Hrdlicková E; Kuwabara I; Dvoránková B; Liu FT; Kaltner H; André S; Gabius HJ
    Prague Med Rep; 2005; 106(2):209-16. PubMed ID: 16315769
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antisense galectin-3 alters thymidine incorporation in human MDA-MB435 breast cancer cells.
    Vandenbrule F; Bellahcene A; Jackers P; Liu F; Sobel M; Castronovo V
    Int J Oncol; 1997 Aug; 11(2):261-4. PubMed ID: 21528209
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Human galectin-8 isoforms and cancer.
    Bidon-Wagner N; Le Pennec JP
    Glycoconj J; 2002; 19(7-9):557-63. PubMed ID: 14758080
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Galectin-1, -3 and -9 Expression and Clinical Significance in Squamous Cervical Cancer.
    Punt S; Thijssen VL; Vrolijk J; de Kroon CD; Gorter A; Jordanova ES
    PLoS One; 2015; 10(6):e0129119. PubMed ID: 26066796
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Galectin expression in urological cancer. Diagnostic, prognostic and therapeutic potential].
    Waalkes S; Merseburger AS; Simon A; Serth J; Kuczyk MA
    Urologe A; 2010 Mar; 49(3):387-91. PubMed ID: 20238481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Galectin-7: a novel gene associated with metastasis].
    Demers M; St-Pierre Y
    Med Sci (Paris); 2005 Oct; 21(10):790-2. PubMed ID: 16197887
    [No Abstract]   [Full Text] [Related]  

  • 59. Towards a Better Understanding of the Relationships between Galectin-7, p53 and MMP-9 during Cancer Progression.
    St-Pierre Y
    Biomolecules; 2021 Jun; 11(6):. PubMed ID: 34198494
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The expression of Galectin-3 in endometrial cancer: a systematic review of the literature.
    Boutas I; Kontogeorgi A; Dimitrakakis C; Kalantaridou SN
    Mol Biol Rep; 2021 Jul; 48(7):5699-5705. PubMed ID: 34241773
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.